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Serviente C, Troy LM, de Jonge M, Shill DD, Jenkins NT,
Witkowski S. Endothelial and inflammatory responses to acute exercise in perimenopausal and late postmenopausal women. Am J Physiol
Regul Integr Comp Physiol 311: R841–R850, 2016. First published
August 17, 2016; doi:10.1152/ajpregu.00189.2016.—Endothelial dysfunction and inflammation are characteristics of subclinical atherosclerosis and may increase through progressive menopausal stages.
Evaluating endothelial responses to acute exercise can reveal underlying dysfunction not apparent in resting conditions. The purpose of
this study was to investigate markers of endothelial function and
inflammation before and after acute exercise in healthy low-active
perimenopausal (PERI) and late postmenopausal (POST) women.
Flow-mediated dilation (FMD), CD31⫹/CD42b⫺ and CD62E⫹ endothelial microparticles (EMPs), and the circulating inflammatory factors monocyte chemoattractant protein 1 (MCP-1), interleukin 8
(IL-8), and tumor necrosis factor-␣ (TNF-␣) were measured before
and 30 min after acute exercise. Before exercise, FMD was not
different between groups (PERI: 6.4 ⫾ 0.9% vs. POST: 6.5 ⫾ 0.8%,
P ⫽ 0.97); however, after acute exercise PERI tended to improve
FMD (8.5 ⫾ 0.9%, P ⫽ 0.09), whereas POST did not (6.2 ⫾ 0.8%,
P ⫽ 0.77). Independent of exercise, we observed transient endothelial
dysfunction in POST with repeated FMD measures. There was a
group ⫻ exercise interaction for CD31⫹/CD42b⫺ EMPs (P ⫽ 0.04),
where CD31⫹/CD42b⫺ EMPs were similar before exercise (PERI:
57.0 ⫾ 6.7 EMPs/l vs. POST: 58.5 ⫾ 5.3 EMPs/l, P ⫽ 0.86) but
were higher in POST following exercise (PERI: 48.2 ⫾ 6.7 EMPs/l
vs. POST: 69.4 ⫾ 5.3 EMPs/l, P ⫽ 0.023). CD62E⫹ EMPs were
lower in PERI compared with POST before exercise (P ⬍ 0.001) and
increased in PERI (P ⫽ 0.04) but did not change in POST (P ⫽ 0.68)
in response to acute exercise. After acute exercise, MCP-1 (P ⫽
0.055), TNF-␣ (P ⫽ 0.02), and IL-8 (P ⬍ 0.001) were lower in PERI
but only IL-8 decreased in POST (P ⬍ 0.001). Overall, these data
suggest that perimenopausal and late postmenopausal women display
different endothelial and inflammatory responses to acute exercise.
menopause; endothelial function; inflammation; acute exercise
CARDIOVASCULAR DISEASE (CVD) is the leading cause of death
for women in developed countries (40) and 1 in 3 women die
from CVD annually (19). Menopause is generally associated
with an increase in CVD risk factors, with an acceleration of
risk that begins during the perimenopausal years and continues
to worsen into postmenopause (38, 39). Ovarian hormones are
generally believed to exert protective cardiovascular effects
(33, 44). Perimenopausal and postmenopausal women differ in
ovarian hormone exposure; perimenopausal women retain intermittent exposure that is absent in postmenopausal women.
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Peri- and postmenopausal women also differ in the length of
time ovarian hormone exposure has been reduced. Interestingly, hormone replacement therapy efficacy varies in women
at different menopausal stages (31, 37), which may be related
to these differences. Because of the accelerated risk that occurs
during perimenopause, and ovarian hormone differences between peri- and postmenopausal women, it is important to
evaluate mechanisms related to increased CVD risk in women
at different menopausal stages. Improved knowledge of CVD
risk accumulation during the menopausal transition may advance efforts to monitor and mediate risk in aging women.
The mechanisms behind adverse changes in CVD risk that
accompany menopause are still unclear but may be related to
changes in ovarian hormones or traditional CVD risk factors
such as blood pressure or lipid levels (38 – 40). These changes,
along with changes in inflammatory cytokines such as monocyte chemoattractant protein 1 (MCP-1), interleukin 8 (IL-8),
and tumor necrosis factor-␣ (TNF-␣) may adversely impact
endothelial function, which itself leads to an increased risk of
cardiovascular disease (7). Endothelial cells are a physical
barrier between blood and blood vessel walls and have a
variety of dynamic properties. Endothelial cells secrete factors
that affect vasomodulation, platelet adhesion and aggregation,
smooth muscle cell migration and proliferation, and inflammation (69). In response to an increase in shear stress, endothelial
cells cause vasodilation via the secretion of nitric oxide (NO)
(50) and can release endothelial microparticles (EMP) indicative of endothelial activation (CD62E⫹) and/or apoptosis
(CD31⫹/CD42b⫺) (12, 71). Inflammation is associated with
oxidation of LDL-cholesterol and expression of cytokines (20,
57). Endothelial function appears to decline through the menopausal transition (46). This decline may be related to changes
in inflammatory cytokines such as MCP-1, IL-8, and TNF-␣,
as these cytokines are involved in the initiation of the inflammatory process and trigger the recruitment of white blood cells
to damaged endothelial cells, potentially leading to the initiation of the atherosclerotic process. As such, they have been
implicated as potential early markers of cardiovascular disease
(3, 41, 61).
Exercise is associated with improved endothelial function.
The endothelial response to acute exercise is attributed to
increased NO bioavailability and decreased vasoconstrictor
factors (i.e., endothelin-1) (20). Acute exercise may also
change markers of endothelial apoptosis and endothelial activation (36) and can transiently increase cytokine expression
(35, 57, 58). Furthermore, the endothelial response to acute
exercise may reveal differences in endothelial function in
groups with differing cardiovascular disease risk, despite sim-
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ilar preexercise function (16, 18). Therefore, we aimed to
assess differences in endothelial function and inflammatory
biomarkers before and after an acute bout of exercise in
perimenopausal and late postmenopausal women. We hypothesized that markers of endothelial dysfunction and inflammation would be higher in late postmenopausal women compared
with perimenopausal women before exercise. After acute exercise, we expected higher levels of inflammation and less of
an endothelial response in the late postmenopausal compared
with the perimenopausal group.
MATERIALS AND METHODS

The study consisted of three visits. The first and second visits were
used for participant screening and to familiarize participants with
study protocols. The third visit assessed endothelial and inflammatory
markers before and after 30 min of moderate-intensity exercise.
Participants. Data collection was completed on 15 participants.
Participants were classified as perimenopausal (n ⫽ 7) or late postmenopausal (n ⫽ 8) based on Stages of Reproductive Aging Workshop ⫹10 guidelines (21): early perimenopausal (n ⫽ 1): variable
menstrual cycle length (⬎7 days different from normal); late perimenopausal (n ⫽ 6): ⱖ60 days but ⬍1 yr of amenorrhea; late
postmenopausal (n ⫽ 8): ⬎5 yr of amenorrhea. Early perimenopausal
and late perimenopausal women were combined for this analysis. No
early postmenopausal (ⱖ1 yr and ⬍5 yr amenorrhea) women were
included.
Participants were screened for cholesterol, triglycerides, fasting
plasma glucose, body fat percentage via dual X-ray absorptiometry,
and blood pressure. Participants were normotensive, nondiabetic, had
normal blood lipid chemistries (LDL-C: ⱕ159 mg/dl, HDL-C⬎40
mg/dl, triglycerides ⬍150 mg/dl), were ⱕ65 yr old, and participated
in ⬍150 min/wk of moderate intensity activity or ⬍75 min/wk of
vigorous intensity activity (accumulated in 10-min bouts). Physical
activity was assessed using the International Physical Activity Questionnaire, which has been validated in this age range (11). Participants
were excluded if they did not meet inclusion criteria or were taking
hormone replacement therapy; were undergoing treatment for menopausal symptoms; had taken oral contraceptives in the past 6 mo; had
a history of cardiovascular disease, myocardial infarction, cardiovascular intervention (e.g., pacemaker implant), chronic menstrual irregularities before menopause; breast cancer, vaginal bleeding, abnormal
uterine/ovary anatomy, venous thromboembolism, acute liver or gallbladder disease; used medications or vitamin/supplements known to
impact endothelial function, such as cholesterol-lowering and/or antiinflammatory medications; or were current smokers or had smoked in
the 6 mo before study enrollment. All experimental protocols were
approved by the Institutional Review Board of the University of
Massachusetts Amherst.
Acute exercise protocol. An incremental treadmill V̇O2 max test was
used to assess peak oxygen consumption (Parvo Medics TrueOne
2400, Sandy, UT) and heart rate using a 12-lead electrocardiogram.
On a separate day, participants walked on a treadmill for 30 min at the
heart rate that corresponded to 60 – 64% of peak oxygen uptake. The
session began and ended with a 5-min warm up and cool down. A
Polar FT1 heart rate monitor (Polar Electro, Lake Success, NY) was
used to verify that the participant maintained the prescribed intensity
throughout the session. Before and 30 min after the acute bout of
exercise, a blood draw and two flow-mediated dilation (FMD) studies,
conducted 15 min apart, were completed.
Flow-mediated dilation. All participants underwent an FMD familiarization trial before data collection. FMD protocols were completed
in the morning to control for diurnal variation, and menstruating early
perimenopausal women were assessed on menstrual cycle days 2–5.
Participants followed a 3-day low-nitrate diet before data collection
and were instructed to fast for 6 h, to avoid exercise, caffeine,

smoking, and alcohol for 12 h, and to stop taking any vitamins and
supplements 72 h before the visit.
FMD was assessed according to published guidelines (66). Briefly,
after 10 min of supine rest, an L-12-5 ultrasound and Doppler probe
with a 60° insonation angle (Philip’s HD11XE Ultrasound System,
Bothell, WA) was used to image the brachial artery proximal to the
cubital fossa. A rapid inflation cuff (D. E. Hokanson, Bellevue, WA)
was placed around the forearm. The brachial artery was continuously
imaged during 2 min of rest, 5 min of forearm cuff inflation (200
mmHg), and 4 min following cuff deflation. Blood pressure and heart
rate were recorded every minute while artery diameter was digitally
captured using FMD Studio Suite Software (FMD Studio, Quipu,
Pisa, Italy). For serial FMD trials, participants rested a minimum of 15
min between studies, and the second study began when baseline
diameter had returned to prestudy values. Arm position, distance to
the cuff, and position of the ultrasound probe were measured and
marked to ensure consistency across trials. Digital video files were
used to analyze baseline and peak diameter. Percent change in
brachial artery diameter was calculated for all studies.
Blood analysis: inflammation, microparticles, and estradiol. Before and 30 min after acute exercise, participants underwent a blood
draw to assess CD31⫹/CD42b⫺ and CD62E⫹ EMPs, MCP-1, IL-8,
and TNF-␣. Failure to obtain blood samples in two of the participants
resulted in analysis of five perimenopausal and eight late postmenopausal women. Inflammatory cytokines were assessed using an MSD
V-Plex Plus Custom Cytokine & Chemokine Assay (Meso Scale
Discovery, Rockville, MD; https://www.mesoscale.com/en/products_
and_services/assay_kits/v-plex/v-plex_product_selector). All samples
were run in triplicate and fell within the assay detection range. The
average coefficients of variation for MCP-1, TNF-␣, and IL-8 were
5.6%, 3.8%, and 2.5%, respectively.
EMP concentrations were determined in batch assays as previously
described (68). Flow cytometry data were analyzed via FlowJo
V10.1r5 (FlowJo, Ashland, OR). EMPs were identified and confirmed
using forward and side scatter parameters of 90 nm calibration beads
(Polysciences, Warrington, PA), and concentrations were calculated
using CountBright Absolute Counting Beads (ThermoFisher Scientific, Waltham, MA). EMPs were defined as CD31⫹/CD42b⫺ (indicative of endothelial apoptosis) and CD62E⫹ (indicative of endothelial
activation) events within the microparticle gate.
17-␤-Estradiol was assessed using a colorimetric ELISA assay
(Invitrogen, Camarillo, CA; https://www.thermofisher.com/order/
catalog/product/KAQ0621). All samples were run in triplicate according to manufacturer instructions. A standard curve was calculated
(r2 ⫽ 0.99) and sample values were fit to the curve. The average
coefficient of variation for samples was 0.27%.
Statistical analysis. All data are presented as means ⫾ SE and were
analyzed using SigmaStat software (Systat Software, San Jose, CA).
Statistical significance in all figures is presented with P values.
Interaction and main effects are noted with lines and individual
comparisons are noted with brackets. Data were evaluated for the
adherence to assumptions for each statistical test proposed. IL-8 data
were normalized using a log-transformation, and estradiol data were
transformed with a square root transformation for analysis. The
nontransformed data are presented for interpretation. Differences
between baseline characteristics were evaluated using independent
t-tests, or if the data did not meet the equal variance assumption, a
Mann-Whitney rank sum test was used. To evaluate differences in
FMD (% change in FMD), EMPs, MCP-1, IL-8, and TNF-␣ concentrations within and between the two menopausal groups before and
after exercise, two-way repeated measures ANOVAs (group ⫻ exercise) were used, followed by Holm-Sidak post-hoc testing.
Post-hoc analyses were performed to assess differences in serial
FMD measurements and to identify any relationships between inflammatory cytokines, estradiol, FMD values, and baseline characteristics.
Serial FMD measurements were assessed with a three-way ANOVA
(group ⫻ exercise ⫻ trial) and Holm-Sidak post-hoc testing. Pearson

AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00189.2016 • www.ajpregu.org
Downloaded from journals.physiology.org/journal/ajpregu at Smith Col Libs (144.121.036.210) on May 5, 2022.

R843

MENOPAUSE, INFLAMMATION, AND ENDOTHELIAL FUNCTION

A
Change in FMD with acute exercise (%)

product moment correlations were used to examine associations
between variables, with the most relevant to the study outcomes
reported.
Regression analysis was performed as an exploratory aim to determine the best predictors of the FMD response to acute exercise. The
dependent variable was the average change in FMD from post- to
preexercise. Forwards and backwards stepwise age-adjusted regression analysis was used to determine variables that were most predictive of the FMD response to acute exercise. Baseline characteristics
[systolic blood pressure (SBP), diastolic blood pressure (DBP), body
fat, V̇O2 peak, HDL-C, LDL-C, TG, and FPG], preexercise endothelial
microparticles, preexercise inflammatory cytokines, preexercise
FMD, and menopausal status (0: perimenopause; 1: postmenopause)
were included in the models. Menopausal status, estradiol, DBP,
LDL-C, V̇O2 peak, preexercise CD31⫹/CD42b⫺ and CD62E⫹ EMPs,
preexercise MCP-1, and preexercise TNF-␣ were selected to include
in the final models. A separate age-adjusted regression analysis was
performed to determine the predictive power of menopausal status on
the FMD response to acute exercise.

8%
6%
4%
2%
0%

- 2%
- 4%
- 6%
Perimenopause

Postmenopause

B

12%

RESULTS

p=0.035

10%

Table 1. Participant characteristics
Years since FMP
Estradiol, pg/ml
Age, yr
Height, cm
Weight, kg
Body fat, %
BMI, kg/m2
V̇O2peak, ml·kg⫺1·min⫺1
HDL-C, mg/dl
LDL-C, mg/dl
FPG, mg/dl
SBP, mmHg
DBP, mmHg
TG, mg/dl
10-year CVD risk, %
MVPA, MET-min/wk

Perimenopausal (n ⫽ 7)

Postmenopausal (n ⫽ 8)

117.3 ⫾ 27.1
47.3 ⫾ 1.5
163.7 ⫾ 3.1
72.9 ⫾ 7.2
40.8 ⫾ 2.6
27.0 ⫾ 2.3
30.1 ⫾ 1.6
70.4 ⫾ 9.7
84.7 ⫾ 8.4
92.4 ⫾ 3.0
104.6 ⫾ 5.6
64.6 ⫾ 4.5
52.0 ⫾ 6.9
1.9 ⫾ 0.3
293.1 ⫾ 98

8.8 ⫾ 1.5
16.5 ⫾ 9.0*
58.9 ⫾ 1.4*
166.5 ⫾ 3.1
69.0 ⫾ 4.3
41.9 ⫾ 1.5
24.8 ⫾ 1.3
28.3 ⫾ 1.1
78.4 ⫾ 4.8
116.5 ⫾ 9.5*
99.5 ⫾ 1.7
117.3 ⫾ 5.2
64.6 ⫾ 2.7
46.4 ⫾ 5.7
3.5 ⫾ 0.6*
100.3 ⫾ 40.9

Participant characteristics for each group are expressed as means ⫾ SE.
FMP, final menstrual period; BMI, body mass index; FPG, fasting plasma
glucose; DBP, diastolic blood pressure; SBP, systolic blood pressure; LDL-C,
low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol;
CVD, cardiovascular disease; MVPA, moderate-to-vigorous physical activity;
MET, metabolic equivalent. *P ⱕ 0.05 for between group comparison.

8%

FMD (%)

Participant characteristics. Baseline characteristics were
similar for perimenopausal and late postmenopausal women
(Table 1). Both groups had statistically similar height, weight,
body fat percentage, body mass index (BMI), V̇O2 peak, highdensity lipoprotein cholesterol (HDL-C), fasting plasma glucose (FPG), SBP, DBP, and self-reported weekly time spent in
moderate-to-vigorous physical activity (MVPA). Late postmenopausal women were significantly older and had higher
LDL-C and lower estradiol compare with perimenopausal
women. Ten-year risk of developing CVD, calculated using the
Framingham Risk Calculator (13), was also significantly
higher in the late postmenopausal group; however, both groups
had relatively low CVD risk. Baseline characteristics were
similar for the subgroups of participants used for EMP and
cytokines analyses; however, LDL-C values did not differ
between groups.
Flow mediated dilation. There was no effect of menopausal
group (P ⫽ 0.234) or exercise (P ⫽ 0.281) on FMD. Before

6%

4%

2%

0%
Perimenopause
Pre-exercise 1

Pre-exercise 2

Postmenopause
Post-exercise 1

Post-exercise 2

Fig. 1. Before and after exercise, two flow-mediated dilation (FMD) trials were
repeated 15 min apart. A: average individual response to acute exercise for
each group. Open circles, individual changes in measurements, with the group
mean represented by the black bar. B: average of individual trials for each
group. The line represents the main effect of trial.

exercise, there were no differences in FMD between groups
(perimenopause: 6.4 ⫾ 0.9% vs. postmenopause: 6.5 ⫾ 0.8%,
P ⫽ 0.97). After exercise, the perimenopausal group tended to
have a higher FMD response compared with preexercise levels
(8.5 ⫾ 0.9%, P ⫽ 0.09), whereas the late postmenopausal
group did not (6.2 ⫾ 0.8%, P ⫽ 0.77). Furthermore, perimenopausal women showed a trend for higher FMD after exercise
compared with late postmenopausal women (P ⫽ 0.063). The
average change in FMD (Fig. 1A) between the two groups was
not statistically different (P ⫽ 0.15). There were no differences
in baseline artery diameter (perimenopause: 3.2 ⫾ 0.1 mm
preexercise vs. 3.2 ⫾ 0.1 mm postexercise; postmenopause:
3.3 ⫾ 0.1 mm vs. 3.3 ⫾ 0.1 mm postexercise) across groups
(P ⫽ 0.53) or with exercise (P ⫽ 0.38).
The effect of serial FMD measurements is controversial in
the literature; some studies have shown no effect of serial
measures (23, 54), whereas others have shown that the first
measurement negatively impacts the second (49). Therefore,
we investigated differences between repeated FMD measures
(Fig. 1B). In perimenopausal women, there was no difference
in FMD between serial measurements (P ⫽ 0.84). However,
the late postmenopausal group had an effect of serial measurements, with a lower FMD response in the second measurement
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compared with the first (P ⫽ 0.035). This effect of serial
measurements is further highlighted by a difference between
perimenopausal and late postmenopausal women in the second
measurement (P ⫽ 0.052) and the trend for a group ⫻ trial
interaction (P ⫽ 0.110). There were similar baseline diameters
between groups (P ⫽ 0.23), for all trials (P ⫽ 0.45), before and
after exercise (P ⫽ 0.68), which reveals that the changes were
not due to differences in starting diameter.
Pearson correlations were used to determine whether any
variables were related to FMD in all participants. There was a
trend for a relationship between the FMD response to acute
exercise and estradiol (r ⫽ 0.50, P ⫽ 0.08).
Endothelial microparticles. For CD31⫹/CD42b⫺ EMPs,
there was a group ⫻ exercise interaction (P ⫽ 0.04). Before
exercise, CD31⫹/CD42b⫺ EMPs were similar in the perimenopausal and late postmenopausal group (perimenopause: 57.0 ⫾
6.7 EMPs/l plasma vs. postmenopause: 58.5 ⫾ 5.3 EMPs/l
plasma, P ⫽ 0.86). After acute exercise, CD31⫹/CD42b⫺
EMPs were higher in the late postmenopausal group compared
with the perimenopausal group (perimenopause: 48.2 ⫾ 6.7
EMPs/l plasma vs. postmenopause: 69.4 ⫾ 5.3 EMPs/l
plasma, P ⫽ 0.023). Furthermore, late postmenopausal women
had a trend for higher postexercise levels (P ⫽ 0.07), whereas
perimenopausal women did not (P ⫽ 0.22) (Fig. 2A). Figure
2B shows the individual data for the difference between groups
in response to acute exercise (P ⫽ 0.062).
For CD62E⫹ EMPs, there was a significant group effect
(P ⫽ 0.002) and a trend for an effect of exercise (P ⫽ 0.06).
Before exercise CD62E⫹ EMPs were significantly lower in the
perimenopausal group (perimenopause: 371.8 ⫾ 61.9 EMPs/l
plasma vs. postmenopause: 673.8 ⫾ 48.2 EMPs/l plasma,
P ⬍ 0.001). In response to acute exercise, CD62E⫹ EMPs
increased in the perimenopausal group but did not change in
the late postmenopausal group (perimenopause: 562.8 ⫾ 60.9
EMPs/l plasma, P ⫽ 0.04; postmenopause: 702.4 ⫾ 48.2
EMPs/l plasma, P ⫽ 0.68) (Fig. 3A), and there was a trend for
a difference between groups after exercise (P ⫽ 0.09). Figure
3B shows the individual data for the difference between groups
in response to acute exercise (P ⫽ 0.19).
Inflammation. For MCP-1 there was a significant group ⫻
exercise interaction (P ⫽ 0.03). Before exercise, there was no
difference in serum MCP-1 between perimenopausal and late
postmenopausal women (perimenopause: 341.5 ⫾ 38.4 pg/ml
vs. postmenopause: 377.2 ⫾ 30.4 pg/ml, P ⫽ 0.48). Perimenopausal women tended to decrease MCP-1, whereas MCP-1 in
late postmenopausal women did not change in response to
acute exercise (perimenopause: 300.2 ⫾ 38.4 pg/ml, P ⫽
0.055; postmenopause: 397.4 ⫾ 30.4 pg/ml, P ⫽ 0.21). Furthermore, there was a trend for a difference between groups
following exercise (P ⫽ 0.07) (Fig. 4A). Figure 4B shows the
individual data for the difference between menopausal groups
in response to acute exercise (P ⫽ 0.043).
There was an overall effect of exercise on TNF-␣ (P ⫽
0.008). There was no difference in serum TNF-␣ between
perimenopausal and late postmenopausal women before exercise (perimenopause: 2.3 ⫾ 0.2 pg/ml vs. postmenopause:
2.6 ⫾ 0.2 pg/ml, P ⫽ 0.30). After exercise, perimenopausal
women had a decrease in TNF-␣, whereas TNF-␣ did not
change in the late postmenopausal group (perimenopause:
1.9 ⫾ 0.2 pg/ml, P ⫽ 0.02; postmenopause: 2.4 ⫾ 0.2 pg/ml,
P ⫽ 0.09) (Fig. 5A). Figure 5B shows the individual data for

p=0.04
p=0.023

p=0.07

80
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Change in CD31+ /CD42b- EMPs with acute exercise
(EMPs/µl Plasma)
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Fig. 2. CD31⫹/CD42b⫺ endothelial microparticles (EMPs) were assessed
before and 30 min after acute exercise. Line represents a group ⫻ exercise
interaction (A). Individual CD31⫹/CD42b⫺ EMPs responses to acute exercise
are represented with open circles. The black bar represents the mean of the
group (B).

the difference between groups in response to acute exercise
(P ⫽ 0.425).
For IL-8, there was a group ⫻ exercise interaction (P ⫽
0.02) and an overall effect of exercise (P ⬍ 0.001). Both
perimenopausal and late postmenopausal women experienced a
decrease in IL-8 compared with preexercise levels (perimenopause: 14.8 ⫾ 3.8 pg/ml, P ⬍ 0.001; postmenopause: 15.3 ⫾
4.1 pg/ml, P ⬍ 0.001). Before exercise, perimenopausal
women had a trend for higher serum IL-8 levels compared with
late postmenopausal women (perimenopause: 146.1 ⫾ 59.7
pg/ml vs. postmenopause: 57.1 ⫾ 13.3 pg/ml, P ⫽ 0.07) (Fig.
6A). Figure 6B shows the individual data for the difference
between groups in the response to acute exercise (P ⫽ 0.093).
Preexercise IL-8 was significantly related to age (r ⫽ ⫺0.65,
P ⫽ 0.02).
Regression analysis. Menopausal status alone only explained 15.3% of the variance in the FMD response to acute
exercise; however, 70% of the variance in the response was
explained when combined with low-density lipoprotein cholesterol, V̇O2 peak, and diastolic blood pressure (Table 2). When
DBP was removed from the model, the predictive power
decreased by ⬃10% (R2 ⫽ 0.604, adjusted R2 ⫽ 0.495,
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Endothelial responses. FMD is a preclinical marker for
cardiovascular disease and is prognostic of cardiovascular
events in postmenopausal women (56). When measured using
established guidelines, FMD is largely NO mediated (66) and
is related to coronary artery function (2). Most studies in
middle-aged and older women have measured FMD after
exercise training, with some reporting increased FMD (28) and
others reporting no change in FMD (47, 64). Assessment of
FMD before and after a single bout of exercise can provide
insight into the ability of the endothelium to respond to this
acute cardiovascular challenge (14, 52) and may elucidate
differences in endothelial function and NO bioavailability that
are not observed at rest. Disparate acute exercise FMD responses have been reported in groups with differing CVD risk.
In overweight active and sedentary men, FMD did not differ
before exercise; however, after acute exercise the sedentary
group had a decreased FMD response, whereas the active
group had an increased FMD response (22). This differential
response to acute exercise has also been shown in smokers
compared with nonsmokers (18) and in obese compared with
lean premenopausal women (17). In the present study, although
most CVD risk factors were similar between groups, late
perimenopausal women had higher 10-yr CVD risk due to
higher age and LDL-cholesterol. In women at distinct meno-

⫹

Fig. 3. CD62E EMPs were assessed before and 30 min after acute exercise
(A). Individual responses to acute exercise are represented with open circles.
Black bar represents the mean of the group (B).

DISCUSSION

Our primary finding was that while there were few baseline
differences between groups, healthy low-active perimenopausal and late postmenopausal women had different endothelial and inflammatory responses to acute exercise. Specifically,
perimenopausal women responded to acute exercise with an
increase in CD62E⫹ EMPs and a trend for an increase in FMD,
along with decreases in the inflammatory cytokines MCP-1,
TNF-␣, and IL-8. Late postmenopausal women had no change
in FMD, CD62E⫹ EMPs, MCP-1, or TNF-␣ and a trend for an
increase in CD31⫹/CD42b⫺ EMPs with acute exercise. Interestingly, late postmenopausal women demonstrated transient
endothelial dysfunction with repeated FMD measurements.
Overall, these results demonstrate that healthy low-active perimenopausal women have more adaptive endothelial and inflammatory responses to acute exercise compared with late
postmenopausal women who demonstrate reduced responsiveness.
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P-value ⫽ 0.014), suggesting that despite its lack of independent statistical significance, DBP has an important influence on
the FMD response to acute exercise.
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Fig. 4. Monocyte chemoattractant protein 1 (MCP-1) was analyzed from
serum samples before and 30 min after acute exercise in both groups. Line
represents a group ⫻ exercise interaction (A). Individual responses to acute
exercise are represented with open circles. Black bar represents the mean of
the group (B).
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Fig. 5. Tumor necrosis factor-␣ (TNF-␣) was analyzed from serum samples
before and 30 min after acute exercise in both groups. Line represents the main
effect of exercise (A). Individual responses to acute exercise are represented
with open circles. Black bar represents the mean of the group (B).
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We found that in late postmenopausal, but not perimenopausal women, serial FMD measurements were associated with
transient endothelial dysfunction that was not caused by differences in artery diameter. A recent review of current literature suggests that there may be a biphasic FMD response after
acute exercise characterized by an initial blunted FMD, followed by an enhanced or normalized FMD (14). Furthermore,
transient endothelial dysfunction has been reported in response
to repeated FMD measurements (15), although it is generally
accepted that serial FMD measures do not impact one another
(23, 53) as the Brachial Artery Reactivity Task Force recommends completing FMD measurements 15 min apart to assess
reproducibility (10). Transient endothelial dysfunction following serial FMD measurements separated by 15 min was previously shown in young healthy men (49). This dysfunction
was ameliorated following supplementation with L-arginine, a
cofactor necessary for the enzymatic production of NO by
endothelial NO synthase, and was associated with elevated
asymmetric dimethylarginine, a NO inhibitor (49). It is possible that the difference in postexercise FMD and the response to
repeated FMD measurements for peri- and late postmenopausal
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pausal stages, Moreau et al. (46) demonstrated that FMD
generally decreased across the menopausal transition. However, when late perimenopausal and late postmenopausal
women were matched for most CVD risk factors, no difference
in FMD was found. Therefore, differences in CVD risk factors
in our population may have contributed to the trend for a
difference in the FMD response to acute exercise and is
supported by a regression analysis where we determined that
the combination of menopausal status, V̇O2 peak, LDL-C, and
DBP predicted 70% of the FMD response to acute exercise.
The FMD response to acute exercise in women at different
menopausal stages has not been well characterized. Studies
comparing responses between pre- and postmenopausal
women reported higher baseline FMD in premenopausal
women compared with postmenopausal women and an enhanced FMD response to acute exercise in postmenopausal, but
not premenopausal women (24, 25). Differences between these
studies and data reported herein could be due to differences in
FMD measurement technique. In the current study, FMD was
measured with cuff placement distal to the imaged region,
which is related to a largely NO-mediated vasodilatory response (66). FMD was measured in the other studies with a
cuff placement proximal to the imaging site on the brachial
artery. Proximal cuff placement is associated with the release
of vasodilatory factors other than NO and/or the arterial myogenic response (66).
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Fig. 6. IL-8 was analyzed from serum samples before and 30 min after acute
exercise in both groups. Line represents a group ⫻ exercise interaction (A).
Individual responses to acute exercise are represented with open circles. Black
bar represents the mean of the group (B).
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Table 2. Age-adjusted models of predictors in flow mediated
dilation
Model (P Value)

Variables

P Value

R2

Adjusted R2

Model 1 (0.15)*
Model 2 (0.029)*

Menopausal status
Menopausal status
LDL-C
V̇O2peak
DBP

0.150
0.004
0.009
0.023
0.153

0.153
0.705

0.088
0.558

Menopausal status (0: perimenopause; 1: postmenopause), LDL-C, lowdensity lipoprotein cholesterol; DBP, diastolic blood pressure. *Model adjusted for age.

women may suggest less NO bioavailability or recovery of NO
production capacity in late postmenopausal women.
The higher levels of estradiol may contribute to greater NO
bioavailability and brachial artery reactivity in the perimenopausal group. Estrogen acts directly on the vasculature and
triggers vasodilation through enhanced NO production, among
other mechanisms (27, 32, 43). Chronic estrogen administration enhances FMD in postmenopausal women (25, 47) and
NO-dependent vasodilation in perimenopausal women (63).
Furthermore, improvements in FMD with exercise training
appear to be dependent on the presence of estrogen (47). The
relationship between estrogen and FMD is supported by the
trend for a positive relationship between estradiol levels and
the FMD response to acute exercise in our data.
EMPs are markers of endothelial activation (CD62E⫹) and
apoptosis (CD31⫹/CD42b⫺) that are released when the endothelium undergoes an acute or chronic stress and provide an
indication of the overall state of the vasculature (12, 71).
Higher circulating levels of EMPs are associated with a variety
of disease states (6, 26, 59) and have been suggested as a novel
biomarker for CVD (1). We observed no difference in CD31⫹/
CD42b⫺ EMPs between perimenopausal and late postmenopausal women before exercise. This is in agreement with
previous literature in pre- and postmenopausal women (34).
After acute exercise, late postmenopausal women had significantly higher CD31⫹/CD42b⫺ EMPs, indicating greater endothelial apoptosis compared with perimenopausal women. This
may suggest that the increased shear stress of unaccustomed
acute exercise has an adverse affect on the endothelium of
low-active late postmenopausal women. To our knowledge,
this is the first study to examine the CD31⫹/CD42b⫺ EMPs
response to acute exercise in peri- and late postmenopausal
women.
CD62E⫹ EMPs have not been previously examined in periversus late postmenopausal women; however, higher values
have been reported in low versus higher estrogen status postmenopausal women (30). Before exercise, CD62E⫹ EMPs
were significantly higher in the late postmenopausal compared
with the perimenopausal group, suggesting increased endothelial activation and an endothelium under greater stress in the
later menopausal stage. The increase in CD62E⫹ EMPs and
endothelial activation in the perimenopausal group is likely due
to the exercise stimulus. Exercise has been previously shown to
stimulate the release of CD62E⫹ EMPs in inactive premenopausal women (16). The lack of a change in CD62E⫹ EMPs
with exercise in late postmenopausal women may indicate a
less responsive endothelium to the acute exercise stimulus due
to higher activation at rest. Overall, the high levels of activa-
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tion before and after exercise and increased apoptosis in
response to acute exercise may suggest a stressed endothelium
in the late postmenopausal group that may contribute to the
lack of FMD response to acute exercise.
Inflammatory responses. MCP-1, TNF-␣, and IL-8 are inflammatory cytokines involved in the initiation of atherosclerosis and have been associated with endothelial dysfunction (4,
5, 29, 48, 51). We hypothesized that because of greater cardiovascular disease risk and lower estradiol, late postmenopausal women would have higher circulating cytokines before
exercise and would respond to acute exercise with an increase
in these factors, when compared with perimenopausal women.
We found that while there were no significant preexercise
between-group differences, the response to exercise differed by
cytokine and menopausal status. To our knowledge, this is the
first study to investigate the response to acute exercise in
women at different menopausal stages.
Estrogen is both anti-oxidative and anti-inflammatory in
nature (32, 42, 62, 63). MCP-1 and TNF-␣ are inhibited by
estrogen through direct and indirect mechanisms (4, 45, 55)
and by NO (67, 72). MCP-1 is higher in older compared with
younger women (60), and transdermal estrogen administration
in postmenopausal women who underwent hysterectomy reduced circulating MCP-1 after 12 mo of therapy (70). In a
cross-sectional comparison of women at different reproductive
stages, MCP-1 was higher in late perimenopausal and postmenopausal women compared with premenopausal women,
but TNF-␣ was similar among groups (65). Although we
anticipated a difference in preexercise MCP-1 and TNF-␣
between groups, and our groups differed by age and circulating
estradiol, they were matched for most other CVD risk factors,
including blood pressure, lipid levels, and body fat, which may
explain a lack of a difference in preexercise levels of these two
cytokines. In fact, Moreau et al. (45) reported no difference in
TNF-␣ between pre- and postmenopausal women who were
matched for most CVD risk factors. Conversely, IL-8 has been
shown to be higher in postmenopausal compared with early
peri- and premenopausal women (65). However, a decrease in
IL-8 with age has also been reported (9, 60). Our data supports
the hypothesis that aging leads to a decrease in IL-8, as age was
negatively associated with preexercise IL-8 in all women.
Generally, MCP-1, TNF-␣, and IL-8 have been reported to
increase 30 – 60 min after acute exercise, although this research
has largely been conducted in young male populations (8, 35,
57, 58). In our study, TNF-␣, MCP-1, and IL-8 decreased with
acute exercise in perimenopausal women, but only IL-8 was
significantly reduced with acute exercise in late postmenopausal women, revealing that acute exercise reduced inflammation to a lesser degree in late postmenopausal women. It is
possible that the decrease in these cytokines in perimenopausal
women is beneficial, as preexercise IL-8 and TNF-␣ were
higher than what has been reported in other acute exercise
studies (8, 35). Decreased IL-8 following acute exercise has
been reported in lean and overweight/obese men and women
and was related to increased expression of the anti-inflammatory cytokine interleukin-10 (15). The response to acute exercise may represent an anti-inflammatory response for perimenopausal women that did not occur to the same extent in late
postmenopausal women.
Limitations. This pilot study provided novel insight into differences in endothelial and inflammatory responses to acute ex-
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ercise in perimenopausal and late postmenopausal but is not
without limitations. First, the cross-sectional nature of the study
does not allow us to infer causation or an independent evaluation
of the effect of age from menopausal status. A sample size
estimation was calculated on the primary outcome, FMD, that
required 12 participants per group to detect baseline differences
and 9 per group to detect differences in response to acute exercise.
Calculations were based on baseline FMD responses in women
across the menopausal transition (46) and changes in FMD after
acute exercise in postmenopausal women (24). Calculations were
completed with a one-tailed test, since we hypothesized that the
FMD response would decrease with later menopausal stages.
Therefore, it is possible that differences between groups may not
have been detected due to the limited statistical power. Furthermore, it is likely that other inflammatory factors or reactive
oxygen species may be involved in the observed endothelial and
inflammatory responses. Future assessment of these markers will
allow for a more complete understanding of changes in both
endothelial function and inflammation and the interaction of these
two factors as women progress through menopause.

3.
4.
5.
6.

7.
8.

9.
10.

Perspectives and Signficance
Our findings indicate that perimenopausal women have
enhanced endothelial function and activation and decreased
inflammation in response to acute exercise. Conversely, the
endothelium of late postmenopausal women is less responsive
to acute exercise and displays transient endothelial dysfunction
with repeated FMD measurements. Overall, these data suggest
that factors related to endothelial responsiveness are reduced in
later menopausal stages. We speculate that intermittent ovarian
hormone exposure in perimenopause is sufficient to reduce
subclinical CVD risk. Further development and evaluation of
strategies to maintain and improve endothelial responsiveness
in women at different menopausal stages are necessary.
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